$23.32
1.79% (Daily)
Market Cap
$1.78B
Revenue
$134.48M
Rank by MCap
#1782
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Kenneth H. Galbraith C.A.
Headquarters
Middletown, DE
Employees
263
Zymeworks Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID). Its therapeutic platforms and fully integrated drug development engine provides the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform...
Loading chart…